Traders debate whether biotech is a buy after bounce

Boris Schlossberg of BK Asset Management and Matt Maley of Miller Tabak break down biotech's prospects with CNBC's Seema Mody.

03:49

Thu, Oct 7 20213:15 PM EDT

RELATED VIDEOS

03:49

Traders debate whether biotech is a buy after bounce

13:20

Bitcoin to $250,000? Why hedge fund manager Mark Yusko believes bitcoin prices will more than quadruple in the next five years

01:54

Why bitcoin bull Mark Yusko is on pullback watch

04:24

Trading Nation: A rush of transports earnings are coming — Here's what to expect

04:55

A CNBC first: Investor executes a Facebook trade in virtual reality

03:56

Trading Nation: Two traders debate the hotel and leisure stocks that are part of Thursday's market rally

05:18

Semiconductor stock strategies for what could be a strong earnings season